- Previous Close
8.71 - Open
8.71 - Bid 8.63 x --
- Ask 9.15 x --
- Day's Range
8.71 - 8.71 - 52 Week Range
8.37 - 9.93 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
637.208M - Beta (5Y Monthly) 0.19
- PE Ratio (TTM)
14.28 - EPS (TTM)
0.61 - Earnings Date May 7, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan. The company's cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, and radio-frequency transseptal needles. Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts, as well as embolic coil deploying systems; and coronary and peripheral intervention products include PTCA and PTA guide wires, and PTCA balloon catheters. In addition, the company offers gastrointestinal intervention products that cholangioscope, biliary tube stent, papillary balloon dilatation catheter, self-expandable duodenal and colonic stent, endoscopic guidewire, and radiofrequency ablation systems; structural heart disease intervention products, such as radiofrequency wires and atrial septal defect closure devices; and neurovascular intervention products. Japan Lifeline Co., Ltd. was incorporated in 1981 and is headquartered in Tokyo, Japan.
www.japanlifeline.comRecent News: L8B.F
View MorePerformance Overview: L8B.F
Trailing total returns as of 4/9/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: L8B.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: L8B.F
View MoreValuation Measures
Market Cap
628.64M
Enterprise Value
602.58M
Trailing P/E
14.23
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.12
Price/Book (mrq)
1.71
Enterprise Value/Revenue
1.74
Enterprise Value/EBITDA
8.13
Financial Highlights
Profitability and Income Statement
Profit Margin
15.05%
Return on Assets (ttm)
10.93%
Return on Equity (ttm)
14.69%
Revenue (ttm)
55.89B
Net Income Avi to Common (ttm)
8.41B
Diluted EPS (ttm)
0.61
Balance Sheet and Cash Flow
Total Cash (mrq)
7.89B
Total Debt/Equity (mrq)
6.40%
Levered Free Cash Flow (ttm)
--